Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110849 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Zhikai Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hand Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; The Second S…. Hauptthemen laut MEDLINE: Surgical Flaps, Nucleobindins, Inflammation, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
OBJECTIVE: Random skin flaps are often placed by plastic surgeons to treat limb deformities and dysfunction. Nesfatin-1 (NES) is a peptide that exerts angiogenic, anti-inflammatory, and anti-oxidant effects. We assessed the impact of NES on flap survival and the underlying mechanism. METHODS: We modified the McFarlane random skin flap rat model. Thirty-six male Sprague-Dawley rats were randomly divided into a control group (corn oil solution with DMSO), low-dose group (NES-L at 10 µg/kg/day), and high-dose group (NES-H at 20 µg/kg/day). On day 7 after surgery, average flap survival areas were calculated. Laser Doppler blood flow monitoring and lead oxide/gelatin angiography were used to evaluate blood perfusion and neovascularization, respectively. Flap histopathological status was evaluated by hematoxylin and eosin (H&E) staining. The levels of superoxide dismutase (SOD) and malondialdehyde (MDA) were determined. Immunohistochemical techniques were used to evaluate the expression of angiogenetic and inflammatory factors. RESULTS: In the experimental groups, the mean skin flap survival areas and blood perfusion increased considerably. The SOD activities in the experimental groups increased and the MDA contents decreased. Immunohistochemically, VEGF expression was upregulated in the experimental groups and the expression levels of inflammatory factors decreased markedly. CONCLUSION: NES inhibited ischemic skin flap necrosis, promoted angiogenesis, and reduced ischemia-reperfusion injury and inflammation. Inhibition of the inflammatory HMGB1-TLR4-NF-κB signal pathway, which reduced flap inflammation and oxidative stress, may explain the enhanced flap survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hand Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, The First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, China.
- Department of Hand Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, China. Electro…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Wenzhou Municipal Science and Technology Bureau
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Jiang, Z., Wang, K., Lin, Y., Zhou, T., Lin, Y., Chen, J., Lan, Q., Meng, Z., Liu, X., Lin, H., & Lin, D. (2023). Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110849
Vancouver
Jiang Z, Wang K, Lin Y, Zhou T, Lin Y, Chen J, et al. Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110849
BibTeX
@article{Jiang2023,
author = {Jiang, Zhikai and Wang, Kaitao and Lin, Yuting and Zhou, Taotao and Lin, Yi and Chen, Jianpeng and Lan, Qicheng and Meng, Zhefeng and Liu, Xuao and Lin, Hang and Lin, Dingsheng},
title = {Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110849}
}
EUVIMED